I don't know Tom but personally I'd say please move 🙂

No longer active here…

Thanks for sharing this Peter, look forward to reading this

Draft document available here: buff.ly/20RW4db

📝 Submit feedback here: buff.ly/bHa1CKk

Funding acknowledgement:
This work is made possible through catalytic support from the Gates Foundation—thank you for championing better, faster TB diagnostics. #Tuberculosis #Diagnostics #GlobalHealth #EvidenceGeneration #WHO #TBScience #Policy #Research

Kyung Hyun Oh · Jean Iragena · Soudeh Ehsani

Steering-group members:
Patricia Hall-Eidson · Alexei Korobitsyn · Carl-Michael Nathanson· Nazir Ismail · Matteo Zignol · Irena Prat · Dr Kerri Viney · Dennis von Berlepsch · Cecily Miller· Avinash Kanchar · Saskia Den Boon · Vineet Bhatia · Martin van den Boom · Ernesto Montero

Observers
Grania Brigden · Puneet Dewan · Smiljka de Lussigny · Adam Penn-Nicholson · Jacob Creswell · Anisa Ghadrshenas

Gavin Churchyard · Yanlin Zhao · Sabira Tahseen · Chishala Chabala · Alex Kay · Nora Engel · Augusto Geyer · Valeria Alcon · Yemisi Takwoingi · Shaheed Vally Omar · Siva Kumar Shanmugam · Daniela Cirillo · Christopher Coulter · Thomas Shinnick · Monde Muyoyeta · Mikashmi Kohli

Contributors 🙌
Claudia Denkinger · Grant Theron · Madhukar Pai · Mark Nicol · Rachel Louise Byrne · Nandita Venkatesan · Tejaswini DV · Jon Deeks · Achilles Katamba · Alice Zwerling · Hojoon Sohn · Holger Schünemann · Emily L MacLean · Anis Karuniawati

Timeline 🗓️ Draft v0 with the Scientific GEG Development Group this month → iterative inputs mid-2025 → open review → publication by year-end. Stay tuned!

Why it matters👇
• Bridges discovery → policy → impact
• Covers diagnostic accuracy, patient outcomes, costs, equity & feasibility
• Speeds scale-up of cutting-edge tools for people affected by TB.

Thanks Kyle! Glad it's still useful. Have you had a look at this as well?

www.who.int/news/item/28...

· establishes two new classes of TB diagnostic technologies for the initial detection of TB and resistance to rifampicin, and

· outlines current WHO TB diagnostic class determination and product assessment definitions and pathways

· presents new recommendations on concurrent testing of respiratory and non-respiratory samples among people of all ages living with HIV and children without HIV or with unknown HIV status
...